Dubai's Abraaj said to be in talks to buy stake in Turkish drugmaker

Sources say private equity firm is keen to acquire stake in Sanovel Ilac Sanayi & Ticaret
By Bloomberg
Thu 28 Dec 2017 01:05 PM

Abraaj Group, the Dubai-based private-equity firm focused on emerging markets, is in talks to buy a stake in Turkish drugmaker Sanovel Ilac Sanayi & Ticaret, according to two people with knowledge of the matter.

Abraaj is considering a minority holding in the Istanbul-based producer of anti-inflammatory, anti-asthmatic and antibiotic medication, said the people, who asked not to be identified because the plan isn’t public. Talks are at a preliminary stage and may not result in a deal, they said.

Sanovel, owned by Turkish businessmen Ahmet Toksoz and Zafer Toksoz, is among the top 10 producers of generic drugs as measured by sales in the country, according to the company’s website.

Abraaj, which manages $13.6 billion of assets, invests in Turkey via a $536 million fund dedicated to assets in the country.

The Dubai-based firm earlier this year purchased 21 percent of logistics company Netlog Lojistik Hizmetleri. This month, it took a minority stake in online travel agent

Abraaj is buying the master franchise of KFC’s regional operations from Yum! Brands, according to a November 16 report in Dunya newspaper.

Abraaj declined to comment. Zafer Toksoz, the deputy chairman of Sanovel, didn’t respond to calls and a text message seeking comment.

For all the latest health tips & news from the UAE and Gulf countries, follow us on Twitter and Linkedin, like us on Facebook and subscribe to our YouTube page, which is updated daily.

Last Updated: Thu 28 Dec 2017 01:03 PM GST

Subscribe to our Newsletter

Subscribe to Arabian Business' newsletter to receive the latest breaking news and business stories in Dubai,the UAE and the GCC straight to your inbox.